arrow
A

Amishi Y. Shah

ut md anderson cancer center
H指数:32
被引数:5,370

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tract

寡转移性膀胱及上尿路尿路上皮癌的转移灶定向放射治疗

2026-01-010
PRE
20Phase II trial of ivonescimab in patients with advanced clear cell renal cell carcinoma previously treated with immune checkpoint blockade: IVORY trial (NCT06940518)

II期临床试验:评估ivonescimab在既往接受过免疫检查点阻断治疗的晚期透明细胞肾细胞癌患者中的疗效(IVORY试验,NCT06940518)。

2025-10-010
OAAI
Phase 2 trial of metastasis directed radiotherapy without systemic therapy (MRWS) for oligometastatic clear cell renal cell carcinoma (ccRCC) and investigation of circulating tumor DNA (ctDNA)

针对寡转移性透明细胞肾细胞癌(ccRCC)的靶向转移放疗(MRWS)且不联合系统治疗的Ⅱ期临床试验,并探究循环肿瘤DNA(ctDNA)

2025-10-010
OAAI
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial

来自随机III期CheckMate 9ER试验的尼鲁单抗联合卡博赞替尼治疗晚期肾细胞癌的最终分析

2025-09-230
OAAI
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial

寡转移性透明细胞肾细胞癌的转移灶定向放射治疗(无系统性治疗):一项单臂、单中心、II期试验的主要疗效分析

2025-09-040
PRE
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146

仑伐替尼联合帕博利珠单抗在免疫检查点抑制剂治疗后转移性透明细胞肾细胞癌患者中的应用:Study 111/KEYNOTE-146研究的结果

2024-11-014
PRE
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy (vol 13, 1970, 2022)
2024-07-040
OAAI
Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial

Nivolumab联合卡博替尼与舒尼替尼一线治疗晚期肾细胞癌: III期随机CheckMate 9ER试验的延长随访

2024-05-0118
OAAI
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract
2023-12-013
PRE
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

免疫检查点疗法治疗转移性肉瘤样和/或横纹肌样肾细胞癌患者的细胞减灭性肾切除术

2023-09-013
OAAI
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma

新辅助sitratinib联合nivolumab在接受肾切除术治疗局部晚期透明细胞肾细胞癌患者中的II期试验

2023-05-1016
OAAI
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies
2023-04-182
OAAI
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
2023-04-0118
OA